MAM
Monaco Asset Management Portfolio holdings
AUM
$264M
This Quarter Return
+5.26%
1 Year Return
+6.34%
3 Year Return
+31.77%
5 Year Return
–
10 Year Return
–
AUM
$226M
AUM Growth
+$226M
(-13%)
Cap. Flow
-$54.5M
Cap. Flow
% of AUM
-24.14%
Top 10 Holdings %
Top 10 Hldgs %
63.96%
Holding
88
New
7
Increased
10
Reduced
28
Closed
28
Top Buys
| 1 |
VanEck Gold Miners ETF
GDX
|
$18.2M |
| 2 |
Viatris
VTRS
|
$5.25M |
| 3 |
Zoom
ZM
|
$4.97M |
| 4 |
Baidu
BIDU
|
$2.98M |
| 5 |
PARA
Paramount Global Class B
PARA
|
$1.53M |
Top Sells
| 1 |
Fate Therapeutics
FATE
|
$13.7M |
| 2 |
Agnico Eagle Mines
AEM
|
$9.38M |
| 3 |
Pfizer
PFE
|
$5.76M |
| 4 |
PayPal
PYPL
|
$4.95M |
| 5 |
B
Barrick Mining Corporation
B
|
$4.48M |
Sector Composition
| 1 | Healthcare | 32.95% |
| 2 | Materials | 27.85% |
| 3 | Technology | 9.58% |
| 4 | Communication Services | 5.15% |
| 5 | Consumer Discretionary | 3.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Oric Pharmaceuticals
ORIC
$1.01B
| $1.79M | 0.54% |
130,000
-150,000
| -54% | -$2.06M |
|
27
B2Gold
BTG
$5.4B
| $1.61M | 0.48% |
617,185
-457,815
| -43% | -$1.19M |
|
|
NBIS
28
Nebius Group N.V. Class A Ordinary Shares
NBIS
$16.1B
| $1.56M | 0.47% |
105,000
| – | – |
|
|
PARA
29
DELISTED
Paramount Global Class B
PARA
| $1.53M | 0.46% |
+130,000
| New | +$1.53M |
|
30
Hanesbrands
HBI
$2.2B
| $1.45M | 0.43% |
250,000
-150,000
| -38% | -$870K |
|
31
Maravai LifeSciences
MRVI
$344M
| $1.37M | 0.41% |
158,151
-153,059
| -49% | -$1.33M |
|
32
JD.com
JD
$43.5B
| $1.37M | 0.41% |
50,000
-115,000
| -70% | -$3.15M |
|
|
MREO
33
Mereo BioPharma
MREO
$275M
| $1.34M | 0.4% |
405,000
-271,494
| -40% | -$896K |
|
34
Forum Energy Technologies
FET
$311M
| $1.19M | 0.36% |
59,604
-10,917
| -15% | -$218K |
|
35
Novavax
NVAX
$1.22B
| $903K | 0.27% |
188,900
+121,751
| +181% | +$582K |
|
|
MAG
36
MAG Silver
MAG
$2.52B
| $869K | 0.26% |
82,200
-169,000
| -67% | -$1.79M |
|
37
Ciena
CIEN
$13.1B
| $865K | 0.26% |
+17,500
| New | +$865K |
|
38
ProQR Therapeutics
PRQR
$235M
| $710K | 0.21% |
312,629
-65,847
| -17% | -$149K |
|
|
NGD
39
New Gold Inc
NGD
$4.63B
| $689K | 0.21% |
405,000
-1,072,753
| -73% | -$1.82M |
|
40
Gossamer Bio
GOSS
$587M
| $656K | 0.2% |
556,000
+276,000
| +99% | +$326K |
|
41
The Mosaic Company
MOS
$10.5B
| $649K | 0.19% |
+20,000
| New | +$649K |
|
42
Cue Biopharma
CUE
$61.5M
| $633K | 0.19% |
334,742
-7,500
| -2% | -$14.2K |
|
43
Alico
ALCO
$257M
| $630K | 0.19% |
21,532
-13,513
| -39% | -$396K |
|
44
VEON
VEON
$3.92B
| $620K | 0.19% |
25,830
+2,030
| +9% | +$48.7K |
|
45
Peloton Interactive
PTON
$2.99B
| $600K | 0.18% |
140,000
-10,000
| -7% | -$42.9K |
|
46
Galapagos
GLPG
$2.07B
| $539K | 0.16% |
16,744
+10,000
| +148% | +$322K |
|
|
DEC
47
Diversified Energy
DEC
$1.24B
| $433K | 0.13% |
+36,000
| New | +$433K |
|
|
TPIC
48
DELISTED
TPI Composites
TPIC
| $146K | 0.04% |
+50,000
| New | +$146K |
|
|
FLG
49
Flagstar Financial, Inc.
FLG
$5.29B
| $41K | 0.01% |
+12,741
| New | +$41K |
|
50
Apple
AAPL
$3.41T
| – | – |
0
| – | – |
|